Internal Medicine Journal

Cover image for Vol. 46 Issue 11

Edited By: Jeff Szer

Impact Factor: 1.526

ISI Journal Citation Reports © Ranking: 2015: 65/155 (Medicine General & Internal)

Online ISSN: 1445-5994



Author Guidelines


MANUSCRIPT SUBMISSION

Thank you for your interest in Internal Medicine Journal. Please read the complete Author Guidelines carefully prior to submission, including the section on copyright. To ensure fast peer review and publication, manuscripts that do not adhere to the following instructions will be returned to the corresponding author for technical revision before undergoing peer review.

Note that submission implies that the content has not been published or submitted for publication elsewhere except as a brief abstract in the proceedings of a scientific meeting or symposium. Once you have prepared your submission in accordance with the Guidelines, manuscripts should be submitted online at http://mc.manuscriptcentral.com/imj

We look forward to your submission.

EDITORIAL AND CONTENT CONSIDERATIONS

Aims and Scope
The Internal Medicine Journal (IMJ) is the official journal of internal medicine of the Adult Medicine Division of The Royal Australasian College of Physicians. Its purpose is to publish high-quality, internationally competitive peer-reviewed, original medical research, both laboratory and clinical, relating to the study and research of human disease. Papers will be considered from all areas of medical practice and science. The journal also has a major role in continuing medical education and publishes review articles relevant to physician education. Research work relating exclusively to paediatrics may be best submitted to the College’s paediatric publication, the Journal of Paediatrics and Child Health.

Peer review
Except where otherwise stated, manuscripts are peer reviewed by anonymous reviewers. The Editor and Publisher reserve the right to modify manuscripts to eliminate ambiguity and repetition, and to improve communication between author and reader.

The Editorial Board reserves the right to refuse any material for publication.

ETHICAL CONSIDERATIONS

Conflict of Interest Disclosure
In accordance with the policies of The Royal Australasian College of Physicians, the Internal Medicine Journal requires that all authors disclose any potential financial or other conflict of interest in discussion with the corresponding author at submission stage. A modified Conflict of Interest form has been adapted from the International Committee of Medical Journal Editors (ICMJE) for the Internal Medicine Journal. The corresponding author only is responsible for signing and completing a single ICMJE form on behalf of all authors for each submission. The form is in four parts.

Publication of articles cannot proceed until the disclosure form has been completed and signed by the corresponding author. Authors can download the COI form when accessing their Author centre on ScholarOne Manuscripts. Log in access is required.

Principles for Publication of Research Involving Human Subjects
Manuscripts must contain a statement to the effect that all human studies have been reviewed by the appropriate ethics committee and have therefore been performed in accordance with the ethical standards laid down in an appropriate version of the Declaration of Helsinki (as revised in Brazil 2013), available at http://www.wma.net/en/30publications/10policies/b3/index.html. It should also state clearly in the text that all persons gave their informed consent prior to their inclusion in the study. Details that might disclose the identity of the subjects under the study should be omitted.

Clinical Audits may be submitted without individual subject consent being obtained provided that the appropriate ethics committee(s) has approved the audit under a Quality Assurance category or Low Risk category with consent waiver. A statement to this effect must accompany the submission.

Clinical Trials Registration
The journal requires that the clinical trials submitted for its consideration are registered in a publicly accessible database. Authors should include the name of the trial register and their clinical trial registration number in the ‘Acknowledgements’ section of their manuscript. If you wish the editor[s] to consider an unregistered trial, please explain briefly why the trial has not been registered.

Trials should be registered at or before the onset of patient enrolment. This policy applies to any clinical trial starting enrolment after July 1, 2008. For trials that began enrolment before this date, we request registration by December 1, 2008, before considering the trial for publication. We define a clinical trial as any research project that prospectively assigns human subjects to intervention or comparison groups to study the cause-and-effect relationship between a medical intervention and a health outcome. Studies designed for other purposes, such as to study pharmacokinetics or major toxicity (e.g., phase 1 trials) are exempt.

We do not advocate one particular registry, but registration with a registry that meets the following minimum criteria:
(1) accessible to the public at no charge;
(2) searchable by standard, electronic (Internet-based) methods;
(3) open to all prospective registrants free of charge or at minimal cost;
(4) validates registered information;
(5) identifies trials with a unique number; and
(6) includes information on the investigator(s), research question or hypothesis, methodology, intervention and comparisons, eligibility criteria, primary and secondary outcomes measured, date of registration, anticipated or actual start date, anticipated or actual date of last follow-up, target number of subjects, status (anticipated, ongoing or closed) and funding source(s).

Registries that meet this criteria include but are not limited to the below:

(1) the registry sponsored by the United States National Library of Medicine (http://www.clinicaltrials.gov);
(2) the International Standard Randomized Controlled Trial Number Registry (http://www.controlled-trials.com);
(3) the Australian New Zealand Clinical Trials Registry (http://www.anzctr.org.au);
(4) the Chinese Clinical Trial Registry (http://www.chictr.org.cn/enindex.aspx);
(5) the Clinical Trials Registry—India (http://ctri.nic.in);
(6) University hospital Medical Information Network (UMIN) (http://www.umin.ac.jp/ctr/).

Research reporting guidelines
Authors are encouraged to use the relevant research reporting guidelines for the study. This will ensure that you provide enough information for editors, peer reviewers and readers to understand how the research was performed and to judge whether the findings are likely to be reliable. The key reporting guidelines are:

Randomised controlled trials (RCTs): CONSORT guidelines
Systematic reviews and meta-analyses: PRISMA guidelines and MOOSE guidelines
Observational studies in epidemiology: STROBE guidelines and MOOSE guidelines
Diagnostic accuracy studies: STARD guidelines
Quality improvement studies: SQUIRE guidelines

Sponsored research
In keeping with College policy, research sponsored directly by tobacco companies will not be considered for publication.

Use of Animals in Research
Any experiments involving animals must be demonstrated to be ethically acceptable and where relevant conform to Australian National Guidelines for animal usage in research.

Authorship and Acknowledgements
The journal adheres to the definition of authorship set up by The International Committee of Medical Journal Editors (ICMJE). The ICMJE recommends that authorship be based on the following 4 criteria: i) Substantial contributions to the conception or design of the work; or the acquisition, analysis, or interpretation of data for the work; ii) Drafting the work or revising it critically for important intellectual content; iii) Final approval of the version to be published; and i) Agreement to be accountable for all aspects of the work in ensuring that questions related to the accuracy or integrity of any part of the work are appropriately investigated and resolved. Contributors who do not qualify as authors should be mentioned under ‘Acknowledgements’.

Committee on Publication Ethics
The journal is a member of, and subscribes to the principles of the Committee on Publication Ethics (COPE).

Plagiarism Detection
The journal employs a plagiarism detection system. By submitting your manuscript to this journal you accept that your manuscript may be screened for plagiarism against previously published works.

MANUSCRIPT CATEGORIES AND WORD LENGTH

In view of current pressures on editorial space, we insist that papers comply with the prescribed word length for article categories. Note that word length refers to the main text of the article. Articles that exceed the prescribed article word length will be withdrawn at submission stage.

Original Articles should not exceed 3000 words and should be arranged under the usual headings of Abstract (less than 250 words), Introduction, Methods, Results, Discussion, Conclusion and References. Papers with poor methodology or poor execution (eg. too many patients lost to follow up) are unlikely to be accepted. Prospective studies are more likely to be accepted than retrospective studies, but only with solid methodology.

Fast track publications should report research findings of international significance which give new insights into the mechanism of a particular disease or have a potential to alter medical practice. Authors may request consideration for fast tracking. Papers not accepted for fast tracking will be considered as standard publications at the author’s request.

Brief Communications should be between 1000 and 1500 words, have no more than 20 references, have a short unstructured abstract no longer than six lines and have no more than two tables or figures. Section headings may be inserted at the discretion of the editor. Papers submitted as original articles may be considered to be more appropriate as Brief Communications. A case report will rarely be suitable for a brief communication and should be submitted as a letter/clinical scientific note.

Letters to the Editor should not exceed 500 words. Short relevant comments on medical and scientific issues, particularly controversies, are encouraged. We encourage authors who submit letters of comment on papers published in the Journal to provide their own article title. Authors will be offered right of reply (no more than 500 words) at the discretion of the Editor and discussion will not be entered into. Reply letters are co-published with the original letter of comment in a print issue. We point out that it is Journal style to publish invited reply letters under the one heading of 'Reply'. To ensure that each letter is self contained and complete for citation purposes, authors who submit invited replies should reference both their original work and the letter which comments on their work. Given the current pressures on editorial space, invited comments are restricted to one reply.

Case Reports are published only if the report is of exceptional interest (i.e. it makes a unique point) with clear proof of cause and effect. Case reports should be restricted to 500 words plus six references, with only one figure or table, and will be subjected to editorial review. The subspecialty editor will decide whether the case study can be upgraded to a Brief Communication. Case reports may not be subject to review if considered of insufficient interest by the Editor. Case reports are published under the subcategory of Clinical-scientific notes which appear under the generic category of Letters to the Editor. These papers are not published on discrete pages.

Reviews are usually solicited. The Editorial Board is open to suggestions for appropriate topics to consider and these should be directed to the relevant subspecialty editor or the Deputy Editor-in-Chief via the Editorial office. Communications should be sent stating the article title, co-author names and affiliations and a brief abstract. Reviews must come from an author who is not acting on behalf of a company and the relationship with any sponsor must be clearly explained at submission time. The policy of the Journal is to publish high-quality review material covering both medical research and practice. An emphasis on evidence based data is important. Studies that comply with evidence based medicine principles are more likely to be accepted. Comprehensive and short reviews are considered. Categories include: (i) Comprehensive Reviews of up to 3500 words and 35 references, (ii) Short Reviews of up to 1500 words and 20 references, (iii) Clinical Perspectives: practical updates of management in major medical disorders of up to 3000 words and 20 references and (iv) short Systematic Reviews with a maximum length of 3500 words. Authors wishing to submit them should check with the subspecialty editor first for suitability of the proposed topic. Papers in this category will be considered as Original Research articles and the methodology of the review specifically evaluated. (v) Current Controversies are of up to 1500 words plus 20 references. In this section attempts will be made to present opposing viewpoints.

Position Papers Major management issues from authoritative specialist societies. These will usually be condensed versions or extracts of larger published statements and will run to a maximum of 1500 words plus 20 references. Background material relating to specific recommendations should, as far as possible, appear as explanatory notes after each recommendation rather than in a separate background statement.

Images in Medicine This series is closed until further notice.

Reports of clinicopathological conferences and hypotheses will be considered if of outstanding merit.

Point of view and historical material Articles of up to 2000 words describing historical aspects of medicine or point-of-view articles pertaining to current aspects of medical practice not suitable for publication as scientific articles.

Ethics in Medicine Series Papers are solicited. In general, articles are clinically oriented. They should be no more than 1500 words with a maximum of eight references. Authors should first contact the Editorial Office.

How I Treat: This series offers an individualistic opinion (not necessarily evidence based) on how to treat a disorder. A word limit of 1500 words with a maximum of 30 references is appropriate. Articles can be either solicited or offered.

PREPARATION OF THE MANUSCRIPT

Pre-acceptance English-language editing
Authors for whom English is a second language may choose to have their manuscript professionally edited before submission to improve the English. Visit our site to learn about the options. All services are paid for and arranged by the author.  Please note using the Wiley English Language Editing Service does not guarantee that your paper will be accepted by this journal.

Optimising Your Article for Search Engines
Many students and researchers looking for information online will use search engines such as Google, Yahoo or similar. By optimising your article for search engines, you will increase the chance of someone finding it. This in turn will make it more likely to be viewed and/or cited in another work. We have compiled these guidelines to enable you to maximise the web-friendliness of the most public part of your article.

Manuscript style

Manuscripts should follow the style of the Vancouver agreement detailed in the ICMJE's revised ‘Uniform Requirements for Manuscripts Submitted to Biomedical Journals: Writing and Editing for Biomedical Publication’, as presented at http://www.ICMJE.org/

Spelling should conform with the Concise Oxford Dictionary. (For example, use 's' not 'z'.)

Measurements and abbreviations. All measurements must be given in SI units as outlined in the latest edition of Units, Symbols and Abbreviations: A Guide for Authors and Editors, 6th edition. Edited by D.N. Baron and H. Mckenzie Clarke (Royal Society of Medicine Press, London, 2008). Statistics and measurements should always be given in numerals (i.e. 10 mm), except where the number begins a sentence. When a number does not refer to a unit of measurement it is spelt out, except where the number is greater than nine.

Acronyms and Abbreviations should be used sparingly and only where they ease the reader’s task by reducing repetition of long, technical terms. Initially use the word in full, followed by the abbreviation in parentheses. Thereafter use the abbreviation. (Abbreviations such as e.g. and i.e. should only be used in parentheses.) A list of acronyms should be provided for original articles, reviews and brief communications. Acronyms in shorter submissions can be left in the body of the paper.

Drugs should be referred to by their generic names, rather than brand names.

Parts of the Manuscript
The manuscript should be submitted in separate files: title page; main text file; figures.

Title page
The title page should contain the following:
(i) A short informative title that contains the major key words. The title should not contain abbreviations.
(ii) Author details, including: the full names of the authors and positions they hold at the time of submission of the manuscript (note that only author affiliations, not author titles, are published in the final article.) The author's institutional affiliations at which the work was carried out. In keeping with the latest guidelines of the ICMJE, each author’s contribution to the paper is to be quantified (see section on Authorship and Acknowledgements above for details).
(iv) The full postal and email address, plus telephone number, of the author to whom correspondence about the manuscript should be sent.
(v) Acknowledgements. The source of financial grants and other funding must be acknowledged, including a frank declaration of the authors’ industrial links and affiliations. The contribution of colleagues or institutions should also be acknowledged. Personal thanks and thanks to anonymous reviewers are not appropriate.
(vi) The word count of both the abstract and main text. (Note that in particular, authors must adhere to the prescribed length for articles, especially Original Articles and Reviews. Original Articles and Reviews may be returned to authors before being considered, if the page length is far in excess of the prescribed limit)
(vii) abstract and key words.
The present address of any author, if different from that where the work was carried out, should be supplied in a footnote.

Abstract and key words
Each original research paper should carry a structured abstract of not more than 250 words presented in the following form. Background: Brief statement of relevant work or clinical situation, and hypothesis, if applicable. Aims: Brief statement of the overall aim. Methods: Laboratory or other techniques used, including statistical analysis. Outcome measures clearly stated. Results: Statistically significant results and relevant negative data cited. Conclusions: Referable to the aims of the study and may include suggestions for future action. Five key words in order of importance for indexing purposes should be supplied below the abstract and should be taken from those recommended by the US National Library of Medicine’s Medical Subject Headings (MeSH) browser list at http://www.nlm.nih.gov/ meshhome.html.

Only a short, unstructured abstract is required for Reviews and Brief Communications. General Correspondence letters do not require an abstract.

Main text
The main text of the manuscript should be presented in the following order: (i) text, (ii) references, (iii) figure legends, (iv) tables (each table on a separate page and complete with title and footnotes), (v) appendices. Figures and supporting information should be submitted as separate files.

Text
Authors should use subheadings to divide sections of their manuscript: Introduction, Materials and Methods, Results, Discussion, Acknowledgements, Conclusion and References. The Methods section should carry a statement confirming clearance of the study by an approved institutional ethics committee. Statistical methods used must be specified.

References
We recommend the use of a tool such as Reference Manager for reference management and formatting.

Reference Manager reference styles can be searched for here: http://refman.com/downloads

In the text, references should be cited using superscript Arabic numerals in the order in which they appear. If cited only in tables or figure legends, number them according to the first identification of the table or figure in the text. In the reference list, the references should be numbered and listed in order of appearance in the text. Cite the names of all authors when there are SIX or fewer; when seven or more list the first six followed by et al. Submissions which do not adhere to these stylistic requirements will be returned for revision. Names of journals should be abbreviated in the style used in Index Medicus.

Reference to unpublished data and personal communications should appear in the text only. References should be listed in the following form.

Journal article
1 Soter NA,Wasserman SI, Austen KF. Cold urticaria: release into the circulation of histamine and eosinophil chemotactic factor of anaphylaxis during cold challenge. N Engl J Med 1976; 294: 687–900.

Online article not yet published in an issue
2 Butterly SJ, Pillans P, Horn B, Miles R, Sturtevant J. Off-label use of rituximab in a tertiary Queensland hospital. Intern Med J doi: 10.1111/j.1445-5994.2009.01988.x

Book
3 Kaufmann HE, Baron BA, McDonald MB,Waltman SR (eds). The Cornea. New York: Churchill Livingstone; 1988.

Chapter in a Book
4 McEwen WK, Goodner IK. Secretion of tears and blinking. In: Davson H (ed.).The Eye,Vol. 3, 2nd edn. New York: Academic Press; 1969; 34–78.

Website references
The website should be treated as any other reference would according to Vancouver reference style. At the first textual citation, a superscript number should be inserted in the text. The details of that website/online article/online report should then be recorded in the list in correct numerical order. Information on websites frequently changes.We require the full website address, including the prefix ‘http://’. In addition, authors should give as much information as possible; that is,

• author name(s)
• editor name(s)
• date of ‘publication’ (when it was written)
• date of citation (this must be given)
• full URL address
• name of online journal (if possible)

We advise authors to test each address before submitting an article.

Journal article on the Internet
1 Abood S. Quality improvement initiative in nursing homes: the ANA acts in an advisory role. Am J Nurs [serial on the Internet] 2002 [cited 12 Aug 2002]; 102. Available from: http://www.nursingworld.org/AJN/2002/june/wawatch.htm

Homepage/website
2 Cancer-Pain.org [homepage on the Internet]. New York: Association of Cancer Online Resources [updated 16 May 2002; cited 9 Jul 2002]. Available from: http://www.cancer-pain.org

Part of a homepage/website
3 American Medical Association [homepage on the Internet]. Chicago: American Medical Association [updated 23 Aug 2001; cited 12 Aug 2002]. AMA Office of Group Practice Liaison. Available from: http://www.ama-assn.org/ama/pub/category/1736.html

Acknowledgements
The source of financial grants and the contribution of colleagues or institutions should be acknowledged.

Tables
Tables should be self-contained and complement, but not duplicate, information contained in the text. Tables should be numbered consecutively in Arabic numerals, with a descriptive, self-explanatory title above the table. Column headings should be brief, with units of measurement in parentheses. All abbreviations should be explained in a footnote. Tables should be double-spaced and vertical lines should not be used to separate columns. Footnotes should be designated by symbols in the following order: †, ‡, §, ¶, etc; significance values should be indicated by *, **, *** etc.

Figure legends
Ensure figures are correctly annotated and described. Legends should be self-explanatory and positioned on a separate page. The legend should incorporate definitions of any symbols used and all abbreviations and units of measurement should be explained. Provide a letter stating copyright authorisation if figures have been reproduced from another source.

Figures
All illustrations (line drawings and photographs) are classified as figures. Figures should be numbered using Arabic numerals, and cited in consecutive order in the text. Each figure should be supplied as a separate file, with the figure number incorporated in the file name. Figures should be sized to fit within the column (82 mm), intermediate (110 mm) or the full text width (170 mm). Magnifications should be indicated using a scale bar on the illustration. Photographs need to be cropped sufficiently or an eyebar used to prevent the subject being recognized, otherwise written permission to publish must be obtained.

Preparation of Electronic Figures for Publication: Although low quality images are adequate for review purposes, publication requires high quality images to prevent the final product being blurred or fuzzy. Advice on figures can be found at Wiley’s guidelines for preparation of figures: http://authorservices.wiley.com/bauthor/illustration.asp

Colour figures
There is no charge for reproducing colour figures.

SUBMISSION REQUIREMENTS

Manuscripts should be submitted online at http://mc.manuscriptcentral.com/imj

• Each manuscript should be accompanied by a cover letter, signed and dated by the corresponding author (electronic signature is acceptable). The cover letter must include:
- The following statement: ‘This work is not under active consideration for publication, has not been accepted for publication, nor has it been published, in full or in part (except in abstract form). I confirm that the study has been approved by (name of committee), an institutional ethics committee.’
- A disclosure statement. The statement must declare any financial support or relationships that may pose conflict of interest. This includes any financial arrangements authors have with a company whose product figures prominently in the submitted manuscript or with a company making a competing product. The absence of any interest to disclose must also be stated.
- If the manuscript reports on investigations on human subjects the cover letter must include a statement that the subject gave informed consent and confirm that patient anonymity is preserved within the text of the manuscript.
- If the manuscript reports on experiments involving animals the cover letter must confirm that paper demonstrates the research to be ethically acceptable and where relevant conforms to Australian National Guidelines for animal usage in research.

• Two Word-files need to be included upon submission: A title page file and a main text file that includes all parts of the text in the sequence indicated in the section 'Parts of the manuscript', including tables and figure legends but excluding figures which should be supplied separately.

• The main text file should be prepared using Microsoft Word, doubled-spaced. All pages should be numbered consecutively in the top right-hand corner, beginning with the first page of the main text file.

• Each figure should be supplied as a separate file, with the figure number incorporated in the file name. For submission, low-resolution figures saved as .jpg or .bmp files should be uploaded, for ease of transmission during the review process. Upon acceptance of the article, high-resolution figures (at least 300 d.p.i.) saved as .eps or .tif files will be required.

PUBLICATION PROCESS AFTER ACCEPTANCE

Accepted papers will be passed to Wiley’s production team for publication. The author identified as the formal corresponding author for the paper will receive an email prompting them to login into Wiley’s Author Services, where via the Wiley Author Licensing Service (WALS) they will be asked to complete an electronic license agreement on behalf of all authors on the paper. More details on the copyright and licencing options for the journal appear below.

Wiley’s Author Services

Author Services enables authors to track their article through the production process to publication online and in print. Authors can check the status of their articles online and choose to receive automated e-mails at key stages of production. The corresponding author will receive a unique link that enables them to register and have their article automatically added to the system. Please ensure that a complete e-mail address is provided when submitting the manuscript. Visit http://exchanges.wiley.com/authors/journal-authors_681.html for more details on online production tracking and for a wealth of resources including FAQs and tips on article preparation, submission and more.

Accepted Articles

The journal offers Wiley’s Accepted Articles service for all manuscripts. This service ensures that accepted ‘in press’ manuscripts are published online very soon after acceptance, prior to copy-editing or typesetting. Accepted Articles are published online a few days after final acceptance, appear in PDF format only, are given a Digital Object Identifier (DOI), which allows them to be cited and tracked, and are indexed by PubMed. After print publication, the DOI remains valid and can continue to be used to cite and access the article. The Accepted Articles service has been designed to ensure the earliest possible circulation of research papers after acceptance. Given that copyright licensing is a condition of publication, a completed copyright form is required before a manuscript can be processed as an Accepted Article. Accepted articles will be indexed by PubMed; therefore the submitting author must carefully check the names and affiliations of all authors provided in the cover page of the manuscript, as it will not be possible to alter these once a paper is made available online in Accepted Article format. Subsequently the final copyedited and proofed articles will appear in an issue on Wiley Online Library; the link to the article in PubMed will automatically be updated.

Proofs

Once the paper has been typeset the corresponding author will receive an e-mail alert containing instructions on how to provide proof corrections to the article. It is therefore essential that a working e-mail address is provided for the corresponding author. Proofs should be corrected carefully; the responsibility for detecting errors lies with the author. The proof should be checked, and approval to publish the article should be emailed to the Publisher by the date indicated; otherwise, it may be signed off on by the Editor or held over to the next issue.

Early View

The journal offers rapid speed to publication via Wiley’s Early View service. Early View articles are complete full-text articles published online in advance of their publication in a printed issue. Early View articles are complete and final. They have been fully reviewed, revised and edited for publication, and the authors' final corrections have been incorporated. Because they are in final form, no changes can be made after online publication. Early View articles are given a Digital Object Identifier (DOI), which allows the article to be cited and tracked before allocation to an issue. After print publication, the DOI remains valid and can continue to be used to cite and access the article. More information about DOIs can be found at http://www.doi.org/faq.html.

Offprints

A PDF reprint of the article will be supplied free of charge to the corresponding author. Additional printed offprints may be ordered online for a fee. Please click on the following link and fill in the necessary details and ensure that you type information in all of the required fields: http://offprint.cosprinters.com/cos. If you have queries about offprints please e-mail: offprint@cosprinters.com.

Author Marketing Toolkit

The Wiley Author Marketing Toolkit provide authors with support on how to use social media, publicity, conferences, multimedia, email and the web to promote their article.

COPYRIGHT, LICENSING AND ONLINE OPEN

Accepted papers will be passed to Wiley’s production team for publication. The author identified as the formal corresponding author for the paper will receive an email prompting them to login into Wiley’s Author Services, where via the Wiley Author Licensing Service (WALS) they will be asked to complete an electronic license agreement on behalf of all authors on the paper.

Authors may choose to publish under the terms of the journal’s standard copyright transfer agreement (CTA), or under open access terms made available via Wiley OnlineOpen.

Standard Copyright Transfer Agreement: FAQs about the terms and conditions of the standard CTA in place for the journal, including standard terms regarding archiving of the accepted version of the paper, are available at: Copyright Terms and Conditions FAQs.

Note that in signing the journal’s licence agreement authors agree that consent to reproduce figures from another source has been obtained.

OnlineOpen – Wiley’s Open Access Option: OnlineOpen is available to authors of articles who wish to make their article freely available to all on Wiley Online Library under a Creative Commons license. With OnlineOpen, the author, the author's funding agency, or the author's institution pays a fee to ensure that the article is made open access. Authors of OnlineOpen articles are permitted to post the final, published PDF of their article on their personal website, and in an institutional repository or other free public server immediately after publication. All OnlineOpen articles are treated in the same way as any other article. They go through the journal's standard peer-review process and will be accepted or rejected based on their own merit.

OnlineOpen licenses. Authors choosing OnlineOpen retain copyright in their article and have a choice of publishing under the following Creative Commons License terms: Creative Commons Attribution License (CC BY); Creative Commons Attribution Non-Commercial License (CC BY NC); Creative Commons Attribution Non-Commercial-NoDerivs License (CC BY NC ND). To preview the terms and conditions of these open access agreements please visit the Copyright Terms and Conditions FAQs.

Funder Open Access and Self-Archiving Compliance: Please click here for more information on Wiley’s compliance with specific Funder Open Access and Self Archiving Policies, and click here for more detailed information specifically about Self-Archiving definitions and policies.

PERMISSION TO REPRODUCE MATERIAL FROM THE JOURNAL

Readers seeking to reproduce parts of an article published in the journal are advised to use the Rightslink service to obtain permission for re-use. Instructions for using Rightslink can be accessed under the ‘Permissions’ tab on the left hand menu, or click here. Authors seeking to reproduce parts of their article published in the journal are advised to consult the terms of their publishing agreement (copyright form or creative commons licence) for allowable re-use. They may also use Rightslink if they do not have ready access to the relevant form.

EDITORIAL CORRESPONDENCE
Enquiries should be addressed to the Editor-in-Chief, Internal Medicine Journal, The Royal Australasian College of Physicians, 145 Macquarie Street, Sydney, New South Wales 2000, Australia. (tel: 61 2 9256 5431; fax: 61 2 9252 3310)

For enquiries regarding ScholarOne Manuscripts submissions please email ManuscriptCentral@racp.edu.au (e.g. IMJ-0000-2015). General enquiries should be directed to Virginia Savickis, the Editorial Office, Internal Medicine Journal (email: imj@racp.edu.au).

Author Guidelines updated 31 August 2015

SEARCH

SEARCH BY CITATION